Literature DB >> 7441008

Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978.

D L Heymann, J S Weisfeld, P A Webb, K M Johnson, T Cairns, H Berquist.   

Abstract

Ebola virus was recovered from a nine-year-old girl who died of acute hemorrhagic fever in June 1977 at Tandala Hospital in northwestern Zaire, in the first reported recognized case of this disease since the discovery epidemics of 1976 in Zaire and Sudan. Investigations undertaken in the Tandala region revealed that two previous clinical infections with Ebola virus had occurred in 1972 and that about 7% of the residents had immunofluorescent antibodies to the virus. Females younger than 30 years of age had a higher prevalence of antibodies than males of comparable age, but above the age of 30 years there was no sex difference. No other clues to the still-mysterious natural reservoir of Ebola virus were uncovered.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7441008     DOI: 10.1093/infdis/142.3.372

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  57 in total

1.  Managing Ebola from rural to urban slum settings: experiences from Uganda.

Authors:  Sam I Okware; Francis Omaswa; Ambrose Talisuna; Jacinto Amandua; Jackson Amone; Paul Onek; Alex Opio; Joseph Wamala; Julius Lubwama; Lukwago Luswa; Paul Kagwa; Thorkild Tylleskar
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

2.  Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide?

Authors:  S Becker; H Feldmann; C Will; W Slenczka
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

3.  Ebola: learn from the past.

Authors:  David L Heymann
Journal:  Nature       Date:  2014-10-16       Impact factor: 49.962

4.  Emergence of divergent Zaire ebola virus strains in Democratic Republic of the Congo in 2007 and 2008.

Authors:  Gilda Grard; Roman Biek; Jean-Jacques Muyembe Tamfum; Joseph Fair; Nathan Wolfe; Pierre Formenty; Janusz Paweska; Eric Leroy
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

5.  Mapping a Filoviral Serologic Footprint in the Democratic Republic of the Congo: Who Goes There?

Authors:  Ian Crozier
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

6.  Ebola virus disease: history, epidemiology and outbreaks.

Authors:  Jacqueline Weyer; Antoinette Grobbelaar; Lucille Blumberg
Journal:  Curr Infect Dis Rep       Date:  2015-05       Impact factor: 3.725

7.  Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys.

Authors:  K M Johnson; L H Elliott; D L Heymann
Journal:  J Clin Microbiol       Date:  1981-11       Impact factor: 5.948

8.  Serologic Evidence of Ebolavirus Infection in a Population With No History of Outbreaks in the Democratic Republic of the Congo.

Authors:  Sabue Mulangu; Vivian H Alfonso; Nicole A Hoff; Reena H Doshi; Prime Mulembakani; Neville K Kisalu; Emile Okitolonda-Wemakoy; Benoit Ilunga Kebela; Hadar Marcus; Joseph Shiloach; Je-Nie Phue; Linda L Wright; Jean-Jacques Muyembe-Tamfum; Nancy J Sullivan; Anne W Rimoin
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

Review 9.  Time From Infection to Disease and Infectiousness for Ebola Virus Disease, a Systematic Review.

Authors:  Gustavo E Velásquez; Omowunmi Aibana; Emilia J Ling; Ibrahim Diakite; Eric Q Mooring; Megan B Murray
Journal:  Clin Infect Dis       Date:  2015-06-30       Impact factor: 9.079

Review 10.  Immune barriers of Ebola virus infection.

Authors:  Anita K McElroy; Elke Mühlberger; César Muñoz-Fontela
Journal:  Curr Opin Virol       Date:  2018-02-16       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.